Torsten Dreier

3.7k total citations
38 papers, 2.6k citations indexed

About

Torsten Dreier is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Molecular Biology. According to data from OpenAlex, Torsten Dreier has authored 38 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Radiology, Nuclear Medicine and Imaging, 14 papers in Immunology and 11 papers in Molecular Biology. Recurrent topics in Torsten Dreier's work include Monoclonal and Polyclonal Antibodies Research (27 papers), Glycosylation and Glycoproteins Research (8 papers) and CAR-T cell therapy research (6 papers). Torsten Dreier is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (27 papers), Glycosylation and Glycoproteins Research (8 papers) and CAR-T cell therapy research (6 papers). Torsten Dreier collaborates with scholars based in Belgium, United States and Germany. Torsten Dreier's co-authors include Patrick A. Baeuerle, Hans de Haard, Peter Kufer, Holger N. Lode, Ralph A. Reisfeld, Ralf C. Bargou, Rong Xiang, Nissi Varki, Gert Riethmüller and Grit Lorenczewski and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Torsten Dreier

35 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Torsten Dreier Belgium	22	1.3k	1.0k	994	964	272	38	2.6k
Ton Logtenberg Netherlands	31	1.6k 1.2×	1.3k 1.3×	454 0.5×	1.7k 1.7×	98 0.4×	82	3.4k
Gundram Jung Germany	31	729 0.6×	1.7k 1.6×	1.4k 1.5×	871 0.9×	85 0.3×	114	2.9k
Neil L. Berinstein Canada	29	472 0.4×	1.3k 1.3×	1.1k 1.1×	792 0.8×	202 0.7×	104	2.9k
B F Haynes United States	33	491 0.4×	1.8k 1.8×	463 0.5×	1.3k 1.4×	109 0.4×	48	3.8k
Katsuyuki Ohmori Japan	30	427 0.3×	1.2k 1.2×	751 0.8×	1.6k 1.7×	50 0.2×	79	3.5k
Carmel M. Lynch United States	13	403 0.3×	406 0.4×	990 1.0×	1.1k 1.1×	178 0.7×	22	2.5k
Raffaella Meazza Italy	32	267 0.2×	2.5k 2.4×	1.1k 1.1×	572 0.6×	103 0.4×	70	3.2k
Aron D. Thall United States	27	348 0.3×	1.4k 1.3×	819 0.8×	900 0.9×	77 0.3×	56	3.4k
Jeanette Dilley United States	24	776 0.6×	930 0.9×	599 0.6×	978 1.0×	49 0.2×	32	2.5k
Aya Jakobovits United States	20	744 0.6×	637 0.6×	705 0.7×	1.4k 1.4×	114 0.4×	36	2.6k

Countries citing papers authored by Torsten Dreier

Since Specialization

Citations

This map shows the geographic impact of Torsten Dreier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Torsten Dreier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Torsten Dreier more than expected).

Fields of papers citing papers by Torsten Dreier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Torsten Dreier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Torsten Dreier. The network helps show where Torsten Dreier may publish in the future.

Co-authorship network of co-authors of Torsten Dreier

This figure shows the co-authorship network connecting the top 25 collaborators of Torsten Dreier. A scholar is included among the top collaborators of Torsten Dreier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Torsten Dreier. Torsten Dreier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kopczynski, Dominik, Waltraud C. Schrottmaier, Cristina Coman, et al.. (2025). Altered platelet lipidome in bleeding patients with unexplained platelet function defects. Haematologica. 111(1). 300–313.

Eichinger, B. E., Torsten Dreier, Alexander Tolios, et al.. (2025). Platelet function analyzer (PFA-100) in patients with mild-to-moderate bleeding disorders and bleeding disorder of unknown cause. Journal of Thrombosis and Haemostasis. 23(7). 2335–2341. 1 indexed citations

Dreier, Torsten, et al.. (2025). Usefulness of Global Coagulation Tests, Thrombin Generation and Viscoelastic Tests for Assessing the Bleeding Phenotype in Rare Coagulation Factor Deficiencies. Hämostaseologie. 45(5). 419–430. 1 indexed citations

Ulrichts, Peter, Antonio Guglietta, Torsten Dreier, et al.. (2018). Neonatal Fc receptor antagonist efgartigimod safely and sustainably reduces IgGs in humans. Journal of Clinical Investigation. 128(10). 4372–4386. 251 indexed citations

Aftimos, Philippe, Christian Rolfo, Sylvie Rottey, et al.. (2017). Phase I Dose-Escalation Study of the Anti-CD70 Antibody ARGX-110 in Advanced Malignancies. Clinical Cancer Research. 23(21). 6411–6420. 47 indexed citations

Klarenbeek, A., Christophe Blanchetot, Wieger Hemrika, et al.. (2016). Combining somatic mutations present in differentin vivoaffinity-matured antibodies isolated from immunizedLama glamayields ultra-potent antibody therapeutics. Protein Engineering Design and Selection. 29(4). 123–133. 9 indexed citations

Hanssens, Valérie, Natalie De Jonge, Anna Hultberg, et al.. (2015). The clinical potential of ARGX-111, an afucosylated anti-MET antibody, in hematological malignancies and suppression of metastasis. Annals of Oncology. 26. ii31–ii31. 3 indexed citations

Basilico, Cristina, Anna Hultberg, Christophe Blanchetot, et al.. (2014). Four individually druggable MET hotspots mediate HGF-driven tumor progression. Journal of Clinical Investigation. 124(7). 3172–3186. 41 indexed citations

Silence, Karen, Torsten Dreier, Mahan Moshir, et al.. (2013). ARGX-110, a highly potent antibody targeting CD70, eliminates tumors via both enhanced ADCC and immune checkpoint blockade. mAbs. 6(2). 523–532. 76 indexed citations

10.

Vandenbroucke, Klaas, Hans de Haard, Els Beirnaert, et al.. (2009). Orally administered L. lactis secreting an anti-TNF Nanobody demonstrate efficacy in chronic colitis. Mucosal Immunology. 3(1). 49–56. 222 indexed citations

11.

Coppieters, Ken, Torsten Dreier, Karen Silence, et al.. (2006). Formatted anti–tumor necrosis factor α VHH proteins derived from camelids show superior potency and targeting to inflamed joints in a murine model of collagen‐induced arthritis. Arthritis & Rheumatism. 54(6). 1856–1866. 239 indexed citations

12.

Schlereth, Bernd, Cornelia Quadt, Torsten Dreier, et al.. (2005). T-cell activation and B-cell depletion in chimpanzees treated with a bispecific anti-CD19/anti-CD3 single-chain antibody construct. Cancer Immunology Immunotherapy. 55(5). 503–514. 77 indexed citations

13.

Dreier, Torsten, Patrick A. Baeuerle, Iduna Fichtner, et al.. (2003). T Cell Costimulus-Independent and Very Efficacious Inhibition of Tumor Growth in Mice Bearing Subcutaneous or Leukemic Human B Cell Lymphoma Xenografts by a CD19-/CD3- Bispecific Single-Chain Antibody Construct. The Journal of Immunology. 170(8). 4397–4402. 155 indexed citations

14.

Wimberger, Pauline, Wei Xiang, Doris Mayr, et al.. (2003). Efficient tumor cell lysis by autologous, tumor‐resident T lymphocytes in primary ovarian cancer samples by an EP‐CAM‐/CD3‐bispecific antibody. International Journal of Cancer. 105(2). 241–248. 27 indexed citations

15.

Baeuerle, Patrick A., et al.. (2003). Specific depletion of autoreactive B lymphocytes by a recombinant fusion protein in vitro and in vivo. International Immunology. 15(7). 789–796. 20 indexed citations

16.

Mayer, Petra, Andreas Wolf, Frank Hanakam, et al.. (2002). In vitro and in vivo activity of MT201, a fully human monoclonal antibody for pancarcinoma treatment. International Journal of Cancer. 100(1). 101–110. 87 indexed citations

17.

Krebs, Barbara, Robert Rauchenberger, Silke U. Reiffert, et al.. (2001). High-throughput generation and engineering of recombinant human antibodies. Journal of Immunological Methods. 254(1-2). 67–84. 130 indexed citations

18.

Lode, Holger N., Torsten Dreier, Rong Xiang, et al.. (1998). Gene therapy with a single chain interleukin 12 fusion protein induces T cell-dependent protective immunity in a syngeneic model of murine neuroblastoma. Proceedings of the National Academy of Sciences. 95(5). 2475–2480. 63 indexed citations

19.

Dreier, Torsten, Holger N. Lode, Rong Xiang, et al.. (1998). Recombinant Immunocytokines Targeting the Mouse Transferrin Receptor: Construction and Biological Activities. Bioconjugate Chemistry. 9(4). 482–489. 21 indexed citations

20.

Schulte, Dorothea, et al.. (1992). Cycloheximide inhibits cellular, but not SV40, DNA replication. FEBS Letters. 299(2). 149–154. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact